Molecular Biology Division


T​his Division quickly identifies and then characterizes newly emerging and reemerging infectious agents to  determine the genetic relatedness and distribution patterns of specific strains of  pathogens of public health importance in support of disease outbreak investigations and surveillance programs, monitors anti-viral/microbial drug resistance, and works closely with local, state and federal agencies to identify suspected agents of bioterrorism using molecular-based testing technologies such as...

  • Nucleic acid amplification assays (real-time PCR) 
  • PFGE pulsed-field gel electrophoresis (DNA 'fingerprinting')
  • Advanced DNA Sequencing Technologies (Next-Gen/Whole Genome Sequencing)
  • Time resolved fluorescence

Division Chief: Robert A. Myers, Ph.D. 

Office: 443-681-3800
Fax: 443-681-4504

Division Manager: Paul Stamper, M.S.P.H.​​

Office: 443-681-3870

Applied Research & Development Program:

Developmental Scientist IIJenny Chen, M.S.​ 

Office: 443-681-3921

Developmental Scientist IIEric Keller, B.S. 

Office: 443-681-4595​

Developmental Scientist II: ​Garima Verma, Ph.D.

Office: 443-681-3874​

Principal Developmental Scientist: ​Victoria Campodónico, MD, PhD, D(ABMM)

Office: 443-681-3940

Biowatch Laboratory

Laboratory Scientist Supervisor: Anish Patel, M.S.
Office: 443-681-3875

Lab: 443-681-4562​

Core Sequencing

Laboratory Scientist SupervisorTerence Moore
Office: 443-681-3922

Laboratory Scientist LeadNeil Chapel​
Office: 443-681-3881

The Core Sequencing Laboratory performs next generation sequencing on viral, bacterial, and fungal pathogens of human health concern.  The data created is used for outbreak detection and investigation, antimicrobial drug resistance monitoring, and pathogen identification.

HIV Diagnostics/Disease Assessment Laboratory

Laboratory Scientist Supervisor: Mark Massey
Office: 443-681-3872

Laboratory Scientist LeadMatt Stielper
Office: 443-681-3877

Instructions- Serological Testing Form with HIV​

Unit processes specimens for HIV screening and confirmation (Antigen/Antibody, molecular testing).
Unit processes specimens to monitor HIV treatment-Lymphocyte Immunophenotyping (flow cytometry, CD4, CD8 enumeration) and HIV-1 viral load. Special permission must be obtained before sending specimens for this testing.

Molecular Diagnostics/Bioterrorism Laboratory

Lab: 443-681-3924
Fax: 443-681-3899/4504

Laboratory Scientist Supervisor: Alex Kim, B.S.
Office: 443-681-3923

Molecular Diagnostic Lead ScientistChristina Taylor
Office: 443-681-3920

Molecular Bioterrorism Lead ScientistSalimatu Lukula, M.S.

Office: 443-681-3905

Run molecular based assays (qPCR, RT-qPCR, etc.) to detect pathogens, agents, and toxins of interest. Provide both clinical diagnostic and epidemiological surveillance data, with local and Federal partners, to help monitor the overall health of Maryland and its residence.

Molecular Epidemiology Laboratory

Laboratory Scientist Supervisor: ​Vacant
Office: 443-681-3873

Laboratory Scientist Lead: John Thoguru
Office: 443-681-3880

Immediate response to State and National Outbreak. Regional Laboratory CDC's Antimicrobial Resistance Laboratory Network (ARLN) See webpage Antibiotic Resistance Laboratory Network (ARLN).
Carbapenem-resistant Enterobacterales (CRE) colonization and isolate testing.
Carbapenem-resistant Acinetobacter baumannii (CRAB) colonization and isolate testing.
Candida auris colonization and isolate testing.